Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transplantation of a beating heart: A first in man.
Yin S, Rong J, Chen Y, Cao L, Liu Y, Mo S, Li H, Jiang N, Shi H, Wang T, Shi Y, Zhu Y, Xiong W, Chen Y, Xu G, Chen X, Chen X, Yin M, Gong F, Huang W, Dong Y, Björn N, Stefan T, Guo Z, He X. Yin S, et al. Among authors: bjorn n. Lancet Reg Health West Pac. 2022 Apr 12;23:100449. doi: 10.1016/j.lanwpc.2022.100449. eCollection 2022 Jun. Lancet Reg Health West Pac. 2022. PMID: 35465045 Free PMC article.
A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease.
Guo Z, Zhao Q, Jia Z, Huang C, Wang D, Ju W, Zhang J, Yang L, Huang S, Chen M, Zhu X, Hu A, Ma Y, Wu L, Chen Y, Han M, Tang Y, Wang G, Wang L, Li L, Xiong W, Zhang Z, Shen Y, Tang Z, Zhu C, Chen X, Hu X, Guo Y, Chen H, Ma Y, Zhang T, Huang S, Zeng P, Lai S, Wang T, Chen Z, Gong J, Yu J, Sun C, Li C, Tan H, Liu Y, Dong Y, Sun C, Liao B, Ren J, Zhou Z, Andrea S, Björn N, Cai C, Gong F, Rong J, Huang W, Guan X, Clavien PA, Stefan TG, Huang J, He X. Guo Z, et al. Among authors: bjorn n. J Hepatol. 2023 Aug;79(2):394-402. doi: 10.1016/j.jhep.2023.04.010. Epub 2023 Apr 20. J Hepatol. 2023. PMID: 37086919 Free article. Clinical Trial.
Pretransplant use of immune checkpoint inhibitors for hepatocellular carcinoma: A multicenter, retrospective cohort study.
Guo Z, Liu Y, Ling Q, Xu L, Wang T, Zhu J, Lin Y, Lu X, Qu W, Zhang F, Zhu Z, Zhang J, Jia Z, Zeng P, Wang W, Sun Q, Luo Q, Hu Z, Zheng Z, Jia Y, Li J, Zheng Y, Wang M, Wang S, Han Z, Yu S, Li C, Zhang S, Xiong J, Deng F, Liu Y, Chen H, Wang Y, Li L, Liang W, Schlegel A, Nashan B, Liu C, Zheng S, He X. Guo Z, et al. Am J Transplant. 2024 Apr 18:S1600-6135(24)00278-8. doi: 10.1016/j.ajt.2024.04.007. Online ahead of print. Am J Transplant. 2024. PMID: 38642712
Enhancer mutations modulate the severity of chemotherapy-induced myelosuppression.
Zhigulev A, Norberg Z, Cordier J, Spalinskas R, Bassereh H, Björn N, Pradhananga S, Gréen H, Sahlén P. Zhigulev A, et al. Among authors: bjorn n. Life Sci Alliance. 2024 Jan 16;7(3):e202302244. doi: 10.26508/lsa.202302244. Print 2024 Mar. Life Sci Alliance. 2024. PMID: 38228368 Free PMC article.
IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors.
Ujvari D, Malyukova A, Zovko A, Yektaei-Karin E, Madapura HS, Keszei M, Nagy N, Lotfi K, Björn N, Wallvik J, Stenke L, Salamon D. Ujvari D, et al. Among authors: bjorn n. Oncoimmunology. 2022 Aug 12;11(1):2109861. doi: 10.1080/2162402X.2022.2109861. eCollection 2022. Oncoimmunology. 2022. PMID: 35979386 Free PMC article.
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.
Malyukova A, Ujvari D, Yektaei-Karin E, Zovko A, Madapura HS, Keszei M, Nagy N, Lotfi K, Björn N, Wallvik J, Tamai M, Nguyen TTT, Akahane K, Inukai T, Stenke L, Salamon D. Malyukova A, et al. Among authors: bjorn n. Cell Death Dis. 2021 Sep 25;12(10):875. doi: 10.1038/s41419-021-04154-0. Cell Death Dis. 2021. PMID: 34564697 Free PMC article.
24 results